<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01063426</url>
  </required_header>
  <id_info>
    <org_study_id>2009-I055</org_study_id>
    <nct_id>NCT01063426</nct_id>
  </id_info>
  <brief_title>Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users</brief_title>
  <acronym>Re-STOP DVT</acronym>
  <official_title>Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users Undergoing Total Knee Replacement Arthroplasty: RE-STOP-DVT Study- A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hallym University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reload of high dose statin may have potential for preventing deep vein thrombosis (DVT) in
      patients on statin undergoing total knee replacement arthroplasty.

      A body of evidence have been reported that reloading of atorvastatin have efficacy in
      reducing periprocedural myocardial infarction and contrast induced nephropathy. These effects
      are considered to be mainly due to their antioxidant anti-thrombotic and anti-inflammatory
      property.

      We, therefore, hypothesize that high dose atorvastatin re-loading may prevent DVT.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">March 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Development of deep vein thrombosis diagnosed and confirmed by CT angiography at lower extremities</measure>
    <time_frame>7days after index surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>D-dimer, lipid panel (Total cholesterol, TG, HDL, LDL), hsCRP, CK, transaminase, ALP</measure>
    <time_frame>7days, 1month, 2month after index surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Thrombosis</condition>
  <condition>Prevention</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Atorvastatin + enoxaparine arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose atorvastatin arm before index surgery+ conventional enoxaparin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Enoxaprin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional Enoxaparin before 12hr and on 1-7th day after index surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High dose Atorvastatin+enoxaparin</intervention_name>
    <description>High dose atorvastatin 80mg/day for 7days after index surgery (total knee replacement arthroplasty, TKRA). At the same time Enoxaparin 40mg SQ/day 12hr before TKRA and from 1day to 7day after TKRA should be administered.</description>
    <arm_group_label>Atorvastatin + enoxaparine arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enoxaparin</intervention_name>
    <description>Enoxaparin 40mg SQ/day 12hr before TKRA and on day 1 to day7 after TKRA should be administered.</description>
    <arm_group_label>Conventional Enoxaprin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are going to receive total knee replacement arthroplasty from any cause.

          -  &lt; 19 years old

        Exclusion Criteria:

          -  patients with cancer

          -  Patients receiving anticoagulant agents from any cause

          -  current statin users

          -  expecting survival from other co-morbidity &lt; 1year

          -  Bed ridden patient

          -  AST, ALT &gt; 3times of upper normal limit

          -  CK&gt; upper normal limit

          -  pregnancy

          -  patients who receives hormone replacement therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang-Ho Jo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallym University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sang-Ho Jo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hallym University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sang-Ho Jo, MD</last_name>
    <phone>82-31-380-3722</phone>
    <email>sophi5@medimail.co.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hallym University Sacred Heart Hospital, Department of Cardiology and Orthopedic Surgery</name>
      <address>
        <city>Anyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>431-070</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Ho Jo, MD</last_name>
      <phone>82-31-380-3722</phone>
      <email>sophi5@medimail.co.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2010</study_first_submitted>
  <study_first_submitted_qc>February 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2010</study_first_posted>
  <last_update_submitted>February 4, 2010</last_update_submitted>
  <last_update_submitted_qc>February 4, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Hallym University Medical Center</name_title>
    <organization>Hallym University Sacred Heart Hospital</organization>
  </responsible_party>
  <keyword>Statin</keyword>
  <keyword>Vein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
    <mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

